|Caspase-8 Inhibitor Z-IETD-FMK
Novel and selective caspase-8 inhibitor
Sample solution is provided at 25 µL, 10mM.
Publications citing ApexBio Products
|Description||Z-IETD-FMK is a specific inhibitor of caspase 8|
|Cas No.||N/A||SDF||Download SDF|
|Chemical Name||(Z)-2-((Z)-(2-((E)-((benzyloxy)(hydroxy)methylene)amino)-1-hydroxy-3-methylpentylidene)amino)-N-((Z)-1-((5-fluoro-1-methoxy-1,4-dioxopentan-3-yl)imino)-1,3-dihydroxybutan-2-yl)-5-methoxy-5-oxopentanimidic acid|
|Solubility||Soluble in DMSO||Storage||Store at -20°C|
|Shipping Condition||Evaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request|
|General tips||For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.|
Z-IETD-FMK is an inhibitor of caspase 8 .
Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. The mechanism of this inhibition of Z-IETD-FMK has been proved not through the effect on IL-2 secretion or IFN-γ production but the decrease of CD25 expression. Experiments show that Z-IETD-FMK has no effect on normal cell growth when there is no activation signal. Z-IETD-FMK has also been found to significantly inhibit NF-κB activation when the concentration is 100μM .
Apart from the ability of inhibiting cell proliferation, Z-IETD-FMK is reported to inhibit TRAIL-mediated killing in cells. It protects the procaspases 9, 2, and 3, and protects PARP to a similar extent in both HCT116 and SW480 cells .
 C.P. Lawrence, S.C. Chow. Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition properties. Toxicology and Applied Pharmacology. 2012, 265: 103-112.
 Nesrin Özören, Kunhong Kim, Timothy F. Burns, et al. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Research. 2000, 60: 6259-6265.